Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment Teva, 1 Aug 2011 Accessed on 21 Feb 2012 from http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-newsArticle&ID=1591070&highlight=laquinimod. CommentRecommendBookmarkWatch